Home / Import refusals / AEK-0766816-2/10002/1A

FDA Import Refusal AEK-0766816-2/10002/1A — Allergan Pharmaceuticals Ireland

Allergan Pharmaceuticals Ireland — FEI 3002806285

The FDA refused shipment AEK-0766816-2/10002/1A from Allergan Pharmaceuticals Ireland (Ireland) on August 18, 2026. The refused product falls under Drugs and Biologics — ONABOTULINUMTOXINA. Cited charges: 118,3280,75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
August 18, 2026
Country
Ireland
Product Category
Drugs and Biologics
Product Code
58PCY05 ONABOTULINUMTOXINA
Charges
118,3280,75

Recent inspections

  • 1194596 (VAI Fri Jun 17 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1117366 (VAI Fri May 04 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1002463 (NAI Fri Dec 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 933338 (VAI Fri Jul 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 842267 (NAI Thu Jul 11 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • 1FX-3872001-8/20002/1C (Fri Sep 25 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 1FX-6585613-0/20002/1F (Sat Sep 19 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 1FX-3169029-1/20002/1F (Fri Sep 18 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-9592363-5/50002/1A (Wed Sep 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-0768113-2/10002/1 (Thu Aug 13 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources